Barclays PLC Leap Therapeutics, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.08 - $3.65 $126,857 - $222,609	-60,989 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$1.35 - $4.01 $82,335 - $244,565	60,989 New	60,989 $244,000
Q2 2021 Aug 13, 2021	SELL	$1.48 - $1.92 $31,672 - $41,088	-21,400 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.82 - $3.01 $38,948 - $64,413	21,400 New	21,400 $41,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.